Stocktoria
POSITRON CORP POSC
OTC · OOTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1994-02-10
POSITRON CORP (POSC) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $461,452 at a -2297.8% net margin.
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Revenue trend · last 7y · down
How it ranks in Manufacturing · percentile among 1829 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| POSC | POSITRON CORP | 2/9 | — | — | — |
| ITOC | iTonic Holdings Ltd | 1/9 | 5.57 | — | — |
| NXL | Nexalin Technology, Inc. | 4/9 | — | — | — |
| VANI | Vivani Medical, Inc. | 1/9 | -14.41 | — | — |
| NRXS | Neuraxis, INC | 3/9 | — | — | — |
| NUWE | Nuwellis, Inc. | 2/9 | — | — | — |
| CV | CapsoVision, Inc | 2/9 | — | — | +15.3% |
FAQ
Is POSC financially healthy?
POSITRON CORP's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does POSC pay a dividend?
No, POSITRON CORP does not currently pay a dividend.
How profitable is POSC?
In FY2025, POSITRON CORP had a net margin of -2297.8% and a return on equity of -734.4%.
Source: SEC EDGAR filings · CIK 0000844985 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.